The S&P 500 (^GSPC) has entered correction, falling 10% from its February all-time highs as political uncertainty has driven ...

A new survey of economists by Bloomberg says they expect two Federal Reserve rate cuts to come in September and December this year, but also weaker growth and higher inflation in 2025.

UiPath (NYSE:PATH – Free Report) had its price target reduced by BMO Capital Markets from $16.00 to $11.50 in a report ...

Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) had its target price boosted by equities researchers at BMO Capital ...

Downbeat retail sales data and Treasury Secretary Scott Bessent's comments are adding to worries about the economy.

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...

On Thursday, BMO Capital Markets sustained their Market Perform rating on Casey’s General Stores (NASDAQ:CASY), with a steady price target of $450.00. The convenience store chain, currently ...

U.S. services sector growth unexpectedly picked up in February and prices for inputs increased, which combined with a recent ...

NFI Group Inc. ( NFI-T) stock could see a big move today after the Winnipeg-based bus maker said it swung to a profit in the ...

Economists had expected the unemployment rate to climb back up to 6.7 per cent in February, according to consensus estimates ...

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of $12 ...